BBY vs DNLI · P/E 14, rev $18.71B vs rev $3.6M
Best Buy Co. Inc (BBY) versus Denali Therapeutics Inc (DNLI) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
Latest reported BBY revenue for 2026-08-01 was $18.71B. Net income was $591.0M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported DNLI revenue for 2026-06-30 was $3.6M. Net income was -$256.0M. DNLI currently screens at market cap $2.11B.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. DNLI currently screens at market cap $2.11B.
Not investment advice. Open the BBY and DNLI stock pages for the full models.
Not investment advice.